Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors

Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors

US Patent 11524010 · Granted Dec 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Uracil derivatives for stimulating read-through of premature termination codons2025
Development of potential antidotes for arsenicals2025
Development of potential antidotes for arsenicals2025
Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and u2025
Development of novel clofarabine analogs for cancer therapy2024
Development of novel clofarabine analogs for cancer therapy2024
Modulators of programmed death-ligand-1 and/or programmed death-ligand-22024
Compounds for the treatment of acute and chronic kidney disease2024
2-pyrimidone analogs as potent antiviral agents against Alphaviruses2024
2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative disease2024
2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative disease2024
Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS vi2024